Q4 2015 Holdings
Filed 2016-02-12 | 75 holdings | $271.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmac Inc(BMRN) | COMMON | 09061G101 | $142.5M | 1,359,922 | 52.6% |
| Biogen Inc(BIIB) | COMMON | 09062X103 | $89.1M | 290,889 | 32.9% |
| Align Tech Inc(ALGN) | COMMON | 016255101 | $25.4M | 386,104 | 9.4% |
| Acadia Healthcare(ACHC) | COMMON | 00404A109 | $9.9M | 158,852 | 3.7% |
| Amphastar Pharmactls(AMPH) | COMMON | 03209R103 | $1.0M | 72,753 | 0.4% |
| Ascendis Pharma A S(ASND) | SP ADR | 04351P101 | $570.0K | 31,100 | 0.2% |
| Coherus Biosciences(CHRS) | COMMON | 19249H103 | $366.0K | 15,940 | 0.1% |
| Gilead Sciences Inc(GILD) | COMMON | 375558103 | $180.4K | 1,782,298 | 0.1% |
| Alexion Pharm Inc(ALXN) | COMMON | 015351109 | $144.6K | 758,180 | 0.1% |
| Celgene Corp(CELG) | COMMON | 151020104 | $141.0K | 1,177,058 | 0.1% |
| Regeneron Pharmctcls(REGN) | COMMON | 75886F107 | $128.3K | 236,300 | 0.0% |
| Incyte Corporation(INCY) | COMMON | 45337C102 | $122.3K | 1,127,423 | 0.0% |
| Vertex Pharmaceuticals(VRTX) | COMMON | 92532F100 | $86.6K | 688,200 | 0.0% |
| Thermo Fisher SCI(TMO) | COMMON | 883556102 | $86.1K | 606,936 | 0.0% |
| Amgen Inc(AMGN) | COMMON | 031162100 | $81.9K | 504,597 | 0.0% |
| Amicus Therapeutics(FOLD) | COMMON | 03152W109 | $77.3K | 7,973,436 | 0.0% |
| Merck & Co Inc(MRK) | COMMON | 58933Y105 | $59.3K | 1,121,925 | 0.0% |
| Seattle Genetics Inc | COMMON | 812578102 | $57.3K | 1,275,775 | 0.0% |
| Acceleron Pharma(XLRN) | COMMON | 00434H108 | $54.7K | 1,121,264 | 0.0% |
| PTC Therapeutics I(PTCT) | COMMON | 69366J200 | $51.4K | 1,586,258 | 0.0% |
| ELI Lilly & Co(LLY) | COMMON | 532457108 | $50.5K | 599,245 | 0.0% |
| Medtronic PLC(MDT) | SHARES | G5960L103 | $41.8K | 543,792 | 0.0% |
| Teva Pharmaceutical(TEVA) | ADR | 881624209 | $39.8K | 605,922 | 0.0% |
| Halozyme Therapeutic(HALO) | COMMON | 40637H109 | $36.0K | 2,075,796 | 0.0% |
| Shire PLC | SP ADR | 82481R106 | $33.8K | 164,674 | 0.0% |
| Intercept Pharmace(ICPTUSD) | COMMON | 45845P108 | $32.9K | 220,047 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $32.5K | 601,910 | 0.0% |
| Alder Biopharmaceu(ALDR1EUR) | COMMON | 014339105 | $30.9K | 934,951 | 0.0% |
| United Therapeutics(UTHR) | COMMON | 91307C102 | $30.6K | 195,280 | 0.0% |
| Dexcom Inc(DXCM) | COMMON | 252131107 | $29.7K | 362,733 | 0.0% |
| Unitedhealth GRP Inc(UNH) | COMMON | 91324P102 | $24.7K | 209,648 | 0.0% |
| ST Jude Medical Inc | COMMON | 790849103 | $24.5K | 397,161 | 0.0% |
| Neurocrine Bioscienc(NBIX) | COMMON | 64125C109 | $23.6K | 416,680 | 0.0% |
| Ophthotech Corp | COMMON | 683745103 | $22.7K | 288,906 | 0.0% |
| Tesaro Inc | COMMON | 881569107 | $21.2K | 405,069 | 0.0% |
| Cara Therapeutics(CARAEUR) | COMMON | 140755109 | $20.4K | 1,212,578 | 0.0% |
| Edwards Lifescience(EW) | COMMON | 28176E108 | $19.8K | 250,295 | 0.0% |
| Uniqure N.V.(QURE) | SHARES | N90064101 | $18.8K | 1,138,513 | 0.0% |
| TG Therapeutics(TGTX) | COMMON | 88322Q108 | $18.2K | 1,521,667 | 0.0% |
| Aimmune Therapeutics(AIMT) | COMMON | 00900T107 | $18.1K | 982,133 | 0.0% |
| Advaxis Inc | COMMON | 007624208 | $18.0K | 1,790,715 | 0.0% |
| Immune Design Corp | COMMON | 45252L103 | $17.2K | 856,867 | 0.0% |
| Intuitive Surgic Inc(ISRG) | COMMON | 46120E602 | $16.9K | 31,030 | 0.0% |
| Novo-Nordisk AS(NVO) | ADR | 670100205 | $16.1K | 277,075 | 0.0% |
| Nxstage Medical | COMMON | 67072V103 | $15.4K | 701,303 | 0.0% |
| Novartis AG(NVSN) | SP ADR | 66987V109 | $15.4K | 178,405 | 0.0% |
| Pronai Therapeutics | COMMON | 74346L101 | $14.4K | 910,566 | 0.0% |
| Sagent Pharmaceuti | COMMON | 786692103 | $12.9K | 810,362 | 0.0% |
| Teladoc Inc(TDOC) | COMMON | 87918A105 | $10.4K | 577,361 | 0.0% |
| Heartware Intl Inc | COMMON | 422368100 | $10.3K | 204,008 | 0.0% |